POSPISILOVA, S., Ivan MALÍK, K. BEZOUSKOVA, Tereza KAUEROVÁ, Peter KOLLÁR, Jozef CSÖLLEI, M. ORAVEC, Alois ČÍŽEK and J. JAMPILEK. Dibasic Derivatives of Phenylcarbamic Acid as Prospective Antibacterial Agents Interacting with Cytoplasmic Membrane. Antibiotics-Basel. BASEL: MDPI, 2020, vol. 9, No 2, p. 1-22. ISSN 2079-6382. Available from: https://dx.doi.org/10.3390/antibiotics9020064.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Dibasic Derivatives of Phenylcarbamic Acid as Prospective Antibacterial Agents Interacting with Cytoplasmic Membrane
Authors POSPISILOVA, S., Ivan MALÍK (703 Slovakia), K. BEZOUSKOVA, Tereza KAUEROVÁ (203 Czech Republic, belonging to the institution), Peter KOLLÁR (203 Czech Republic, belonging to the institution), Jozef CSÖLLEI (203 Czech Republic, belonging to the institution), M. ORAVEC, Alois ČÍŽEK (203 Czech Republic) and J. JAMPILEK.
Edition Antibiotics-Basel, BASEL, MDPI, 2020, 2079-6382.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.639
RIV identification code RIV/00216224:14160/20:00116288
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.3390/antibiotics9020064
UT WoS 000519242200040
Keywords in English carbamate; antibacterial; synergy; antibiofilm activity; structure-activity relationships
Tags rivok, ÚChL, ÚFTo
Tags International impact, Reviewed
Changed by Changed by: Mgr. Hana Hurtová, učo 244985. Changed: 24/3/2021 16:36.
Abstract
1-[2-[({[2-/3-(Alkoxy)phenyl]amino}carbonyl)oxy]-3-(dipropylammonio)propyl]pyrrolidinium/azepan- ium oxalates or dichlorides (alkoxy = butoxy to heptyloxy) were recently described as very promising antimycobacterial agents. These compounds were tested in vitro against Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 (reference and control strains), three methicillin-resistant isolates of S. aureus, and three isolates of vancomycin-resistant E. faecalis. 1-[3-(Dipropylammonio)-2-({[3-(pentyloxy-/hexyloxy-/heptyloxy)phenyl]carbamoyl}oxy)propyl]pyrrolidinium dichlorides showed high activity against staphylococci and enterococci comparable with or higher than that of used controls (clinically used antibiotics and antiseptics). The screening of the cytotoxicity of the compounds as well as the used controls was performed using human monocytic leukemia cells. IC50 values of the most effective compounds ranged from ca. 3.5 to 6.3 mu M, thus, it can be stated that the antimicrobial effect is closely connected with their cytotoxicity. The antibacterial activity is based on the surface activity of the compounds that are influenced by the length of their alkoxy side chain, the size of the azacyclic system, and hydro-lipophilic properties, as proven by in vitro experiments and chemometric principal component analyses. Synergistic studies showed the increased activity of oxacillin, gentamicin, and vancomycin, which could be explained by the direct activity of the compounds against the bacterial cell wall. All these compounds demonstrate excellent antibiofilm activity, when they inhibit and disrupt the biofilm of S. aureus in concentrations close to minimum inhibitory concentrations against planktonic cells. Expected interactions of the compounds with the cytoplasmic membrane are proven by in vitro crystal violet uptake assays.
PrintDisplayed: 7/8/2024 06:19